Michael Gelband’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-138,618
| Closed | -$1.58M | – | 2167 |
|
|
2025
Q4 | $1.58M | Buy |
138,618
+107,934
| +352% | +$1.27M | 0.01% | 840 |
|
|
2025
Q3 | $389K | Buy |
+30,684
| New | +$445K | ﹤0.01% | 1242 |
|
|
2025
Q2 | – | Sell |
-204,956
| Closed | -$3.06M | – | 2036 |
|
|
2025
Q1 | $3.06M | Buy |
+204,956
| New | +$3.63M | 0.03% | 553 |
|
|
2024
Q4 | – | Sell |
-7,696
| Closed | -$208K | – | 2136 |
|
|
2024
Q3 | $208K | Buy |
+7,696
| New | +$197K | ﹤0.01% | 1447 |
|
|
2024
Q2 | – | Sell |
-11,586
| Closed | -$385K | – | 2052 |
|
|
2024
Q1 | $385K | Sell |
11,586
-153,269
| -93% | -$5.24M | ﹤0.01% | 1200 |
|
|
2023
Q4 | $5.87M | Buy |
164,855
+110,995
| +206% | +$3.52M | 0.04% | 313 |
|
|
2023
Q3 | $1.84M | Buy |
53,860
+5,627
| +12% | +$214K | 0.02% | 700 |
|
|
2023
Q2 | $1.93M | Sell |
48,233
-76,863
| -61% | -$3.06M | 0.02% | 816 |
|
|
2023
Q1 | $4.91M | Sell |
125,096
-18,066
| -13% | -$663K | 0.04% | 523 |
|
|
2022
Q4 | $4.56M | Buy |
143,162
+25,825
| +22% | +$779K | 0.07% | 376 |
|
|
2022
Q3 | $3.33M | Buy |
+117,337
| New | +$4.01M | 0.04% | 554 |
|
|
2022
Q2 | – | Sell |
-17,546
| Closed | -$864K | – | 2528 |
|
|
2022
Q1 | $864K | Buy |
+17,546
| New | +$928K | 0.01% | 1242 |
|
|
2021
Q4 | – | Sell |
-18,414
| Closed | -$1.07M | – | 2665 |
|
|
2021
Q3 | $1.07M | Sell |
18,414
-130,511
| -88% | -$8.04M | 0.01% | 992 |
|
|
2021
Q2 | $9.42M | Buy |
148,925
+38,087
| +34% | +$2.51M | 0.1% | 162 |
|
|
2021
Q1 | $7.07M | Buy |
110,838
+78,292
| +241% | +$4.54M | 0.1% | 183 |
|
|
2020
Q4 | $1.7M | Buy |
32,546
+24,468
| +303% | +$1.21M | 0.02% | 604 |
|
|
2020
Q3 | $353K | Buy |
8,078
+3,394
| +72% | +$150K | 0.01% | 1202 |
|
|
2020
Q2 | $206K | Buy |
+4,684
| New | +$198K | 0.01% | 1510 |
|
|
2020
Q1 | – | Sell |
-25,400
| Closed | -$1.44M | – | 1705 |
|
|
2019
Q4 | $1.44M | Sell |
25,400
-25,012
| -50% | -$1.39M | 0.03% | 428 |
|
|
2019
Q3 | $2.69M | Buy |
50,412
+44,601
| +768% | +$2.4M | 0.09% | 183 |
|
|
2019
Q2 | $339K | Sell |
5,811
-18,651
| -76% | -$1M | 0.01% | 633 |
|
|
2019
Q1 | $1.21M | Buy |
+24,462
| New | +$1.08M | 0.09% | 161 |
|
Other funds holding XRAY
SCA
CB
AI
Michael Gelband's XRAY Position: Q1 2026 in Review
Michael Gelband sold out of Dentsply Sirona (XRAY) in Q1 2026, closing a stake of 138,618 shares — an estimated $1.58M sold.
Michael Gelband first reported a position in XRAY in Q1 2019 and held it in 22 quarters. The position peaked at $9.42M in Q2 2021. 385 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.
- Michael Gelband reported no remaining Dentsply Sirona position as of Q1 2026 after selling out during the quarter.
- Michael Gelband sold 138,618 Dentsply Sirona shares in Q1 2026, an estimated $1.58M.
- Michael Gelband first reported a position in Dentsply Sirona in Q1 2019 and held it in 22 quarters.
- Michael Gelband's Dentsply Sirona position peaked at $9.42M in Q2 2021.
- 385 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.
Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.